Top list · Worldwide
96 vaccines startups worldwide have raised money in rounds we track. These are the 50 that have raised the most, $13B between them, with the United States the most common home.
GPN Vaccines is a clinical-stage biotechnology company based in Adelaide and Canberra, Australia, founded in 2017.
Founded 2017Canberra, United States$10Blast round Nov 2026Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Founded 2013San Carlos, United States$633Mlast round Jan 2026Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
Founded 2013Saint-herblain, France$310Mlast round Apr 2026Abogen Biosciences is a clinical-stage biotechnology company focused on RNA-based medicines, particularly in mRNA science and technology.
Founded 2019Wuxi, China$300Mlast round Nov 2021MedAccess is a London-based, independent, not-for-profit social enterprise established in 2017.
Founded 1998Kelowna, United States$200Mlast round Dec 2017Panacea Biotec is a research-based health management company involved in research, manufacturing and marketing of high-quality, affordable pharmaceutical, vacci
Founded 1994New Delhi, India$144Mlast round Apr 2019Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Founded 2017Seattle, United States$119Mlast round May 2023Curevo is a clinical-stage biotech firm that focuses on producing vaccines.
Founded 2018Bothell, United States$110Mlast round Mar 2025Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.
Founded -London, United Kingdom$100Mlast round Sept 2024HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
Founded 2021Boston, United States$100Mlast round Sept 2023Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.
Founded 2007United States$99Mlast round Aug 2014Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.
Founded 2008United States$99Mlast round Jun 2014Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses.
Founded 2019China$83Mlast round Mar 2024ImmusanT develops therapeutic vaccines for the treatment of celiac disease.
Founded 2010Cambridge, United States$72Mlast round Nov 2017LigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for gastrointestinal and respiratory indications.
Founded 1998United States$72Mlast round Jun 2012Juvaris BioTherapeutics develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious diseases.
Founded 2001Pleasanton, United States$55Mlast round Oct 2010Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called
Founded 1997United States$54Mlast round Jan 2003Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.
Founded -Cambridge, United States$50Mlast round Mar 2026DIOSynVax is a clinical-stage biotechnology company based in Cambridge, UK, focused on developing next-generation vaccines using advanced computational design a
Founded 2017Cambridge, United Kingdom$44Mlast round Jun 2025Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.
Founded 2017Lyon, France$39Mlast round Aug 2025NovaDigm Therapeutics develops vaccines that protect patients from contracting fungal and bacterial infections.
Founded 2005United States$35Mlast round Oct 2013Meissa Vaccines is a clinical-stage biotechnology company based in Redwood City, California, founded in 2014.
Founded 2014San Rafael, United States$33Mlast round Sept 2019Ember LifeSciences is a healthcare technology company based in Westlake Village, California, specializing in cold chain solutions for transporting temperature-s
Founded 2012Westlake Village, United States$32Mlast round Aug 2026Infinitopes Ltd.
Founded 2021Oxford, United Kingdom$32Mlast round Jan 2026Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.
Founded 2010Oslo, Norway$32Mlast round Jun 2026GlycoVaxyn develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology.
Founded 2004Switzerland$32Mlast round Mar 2009TheraVectys is a clinical-stage biotechnology company based in Paris, France, founded in 2005 as a spin-off from the Institut Pasteur.
Founded 2005Paris, France$30Mlast round Jan 2015An organization dedicated to the production of high quality vaccines and biopharmaceuticals
Founded 2011Kingston$29Mlast round Oct 2017VAXDYN is a Spanish biotechnology startup based in Seville, founded in 2011.
Founded 2011Sevilla, Spain$26Mlast round Sept 2026Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.
Founded 2018Cincinnati, United States$26Mlast round Sept 2026Aston Sci.
Founded 2018South Korea$25Mlast round Jan 2021Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
Founded 2012Boston, United States$23Mlast round Apr 2025NeoVac is a clinical-stage company creating a revolutionary, unique and proprietary next-generation lipid nanoparticles platform to enable better RNA vaccines a
Founded 2021Abingdon, United Kingdom$23Mlast round Sept 2025Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.
Founded 2007Switzerland$21Mlast round Sept 2010Immune Targeting Systems develops synthetic vaccines for mutating viruses, improving the quality of life for those infected by viruses.
Founded 2003United Kingdom$20Mlast round Mar 2010Innovac Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2022.
Founded -Cambridge, United States$18Mlast round Sept 2023Micron Biomedical is a clinical-stage biopharmaceutical company based in Atlanta, Georgia.
Founded 2014Atlanta, United States$16Mlast round Jan 2025Delonix Bioworks is a biotech company based in Shanghai, China, specializing in the development of genetically engineered bacterial vaccines.
Founded 2020Shanghai, China$14Mlast round Mar 2021Si'ao Biotechnology engages in the development and production of genetic engineering vaccines and test kits.
Founded 2012Suzhou$14Mlast round Jul 2018PDC*line Pharma is a clinical-stage biotechnology company founded in 2014, specializing in the development of therapeutic cancer vaccines.
Founded 2014Liege, France$13Mlast round Dec 2021Hawaii Biotech, Inc., a biotechnology company, focuses on the research and development of prophylactic vaccines for infectious diseases.
Founded 1982Honolulu, United States$12Mlast round Feb 2014AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines.
Founded 2017Hørsholm, Denmark$12Mlast round Jun 2025Baseimmune is a London-based biotechnology company founded in 2019, specializing in the development of mutation-proof, universal vaccines and active immunothera
Founded 2019London, United Kingdom$11Mlast round Feb 2024Edge Animal Health offers biotechnology solutions that focus on a bi-directional approach to develop novel therapeutics and vaccines.
Founded 2020New Jersey$11Mlast round Jun 2024Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.
Founded -Framingham, United Kingdom$10Mlast round Jan 2014Vaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases.
Founded 2021Dallas, United States$9.3Mlast round Apr 2022Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.
Founded 2013San Diego, United States$9.0Mlast round Sept 2023Madison Vaccines develops vaccines for patients with prostate cancer and a test to identify such patients.
Founded 2012United States$8.0Mlast round Jan 2014LinKinVax is a clinical-stage biotechnology startup based in Paris, France, founded in 2020.
Founded 2020Paris, France$7.8Mlast round Jan 2023Companies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back vaccines startups worldwide in the app, with filters, lists and exports.
GV
V
RPHealth startups worldwide12,811 companies · $81B
O
A
XAI startups worldwide10,238 companies · $830B
GV
V
RPBiotech startups worldwide7,127 companies · $70B
D
B
FTBig data startups worldwide3,812 companies · $220BAF
R
SFintech startups worldwide3,200 companies · $94B
O
A
BAI startups that raised in 20262,922 companies · $540B in 2026
FT
CE
PEnergy providers startups worldwide2,808 companies · $152B
P
OMarketing tech startups worldwide2,728 companies · $28B